Riamilovir sodium (Triazavirin) is a novel guanine nucleoside analogue and broad-spectrum antiviral candidate. It completely blocks viral RNA synthesis and transcription by competitively inhibiting viral RNA-dependent RNA polymerase, demonstrating exceptionally potent in vitro neutralizing activity against various strains, including H5N1 avian influenza and multidrug-resistant variants.
Molekulargewicht:
250.17
Reinheit:
99.91%
CAS Nummer:
[116061-59-7]
Formel:
C5H3N6NaO3S
Target-Kategorie:
DNA/RNA Synthesis
T212727
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten